Arcutis Biotherapeutics

Arcutis Biotherapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Arcutis Biotherapeutics is a company listed under the stock ticker ARQT (US).

View the org chart displaying its 32 main executives

Most searched biographies at Arcutis Biotherapeutics

• Frank Watanabe, Director, President and Chief Executive Officer
• Halley Gilbert, Director
• Howard Welgus, Director

Popular executive movements at Arcutis Biotherapeutics

• David Chu, Vice President, Clinical Development, has left the company  (posted on March 5 2025).
• Kent Taylor, who was Vice President, Sales, is promoted to Senior Vice President of Sales  (posted on December 5 2024).
• Todd Edwards, who was Chief Commercial Officer, is promoted to Executive Vice President, Chief Commercial Officer  (posted on December 5 2024).

Click here to view some more movements at Arcutis Biotherapeutics

Create your alert
to follow the executive moves at Arcutis Biotherapeutics.

Arcutis Biotherapeutics has 2,345 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Genus (United Kingdom (UK)).

Popular M&A news in Biotechnology

• Purespring Therapeutics has just announced a $105 Million fundraising (posted on March 14 2025).
• Bristol-Myers Squibb has announced the acquisition of 2Seventy Bio  (posted on March 11 2025).
• Callio Therapeutics has just announced a $187 Million fundraising (posted on March 7 2025).

Popular contacts in Biotechnology

• Kristina Burow - Director at Scholar Rock
• Steven Gillis - Chairman of the Board at VBI Vaccines
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics

Learn more about the Biotechnology industry >

Press releases by Arcutis Biotherapeutics

Social media about Arcutis Biotherapeutics

• Arcutis Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Arcutis Biotherapeutics on LinkedIn, Twitter & YouTube